Annotation Detail for CD19

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04640 | Hematopoietic cell lineage |
hsa05340 | Primary immunodeficiency |
hsa04662 | B cell receptor signaling pathway |
Pathway ID | Pathway Name |
---|
| Signaling in Immune system |
Pathway ID | Pathway Name |
---|
200005 | BCR signaling pathway |
Pathway ID | Pathway Name |
---|
P00010 | B cell activation |
Pathway ID | Pathway Name |
---|
500477 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
Desease ID | Desease Name |
---|
1704 | Common variable immunodeficiency |
1818 | Systemic scleroderma |
1973 | Hypogammaglobulinemia |
2051 | Leukemia |
Desease Name |
---|
rheumatoid arthritis |
sclerosis, systemic |
systemic lupus erythematosus |
IMMUNE |
Crohn's disease |
Desease Name |
---|
Antibody deficiency due to defect in CD19 |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in decreased expression of CD19 mRNA | decreases expression | 19925653
|
D002392 |
Catechin |
Catechin results in increased expression of CD19 mRNA | increases expression | 15465739
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased expression of CD19 protein | increases expression | 10813102
|
D010126 |
Ozone |
TTPA protein affects the reaction [Ozone results in decreased expression of CD19 mRNA] | affects reaction|decreases expression | 19555225
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CD19 mRNA | decreases expression | 17426115
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.02 | 16434500 |
MESH:D000361 |
Agammaglobulinemia |
marker/mechanism |
|
| 16672701 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.50 | 15513908 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.62 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.72 | 16373670 17854713 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.52 | 19483382 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.96 | 18315731 16777450 15516495 14754758 18417511 19059883 17626835 |
MESH:D002100 |
Cachexia |
|
Ozone |
5.28 | 16183385 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.08 | 19176532 |
MESH:D017074 |
Common Variable Immunodeficiency |
marker/mechanism |
|
| 16672701 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.85 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.14 | 19236843 20131406 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.48 | 18467677 19772884 19176532 16221962 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Catechin |
5.30 | 17292331 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
4.85 | 17604070 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
5.21 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
5.21 | 15890375 16377806 20007298 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.60 | 8266340 19066396 |
MESH:D055370 |
Lung Injury |
|
Ozone |
4.33 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
3.06 | 11696405 15390079 11246140 16337739 19359593 18597497 19925653 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.06 | 7614698 8597069 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
3.96 | 1500032 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.72 | 10496685 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.09 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.61 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
13.19 | 11893704 |
MESH:D011014 |
Pneumonia |
|
Ozone |
13.19 | 18007984 18929643 18381685 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
ethinyl estradiol-desogestrel combination |
5.98 | 17105841 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D019851 |
Thrombophilia |
|
ethinyl estradiol-desogestrel combination |
6.23 | 11994571 |
MESH:D020246 |
Venous Thrombosis |
|
ethinyl estradiol-desogestrel combination |
6.12 | 15869587 |
PharmGKB Accession:PA26192
Releated disease ID |
Related disease Name |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |